Additionally, proteins, such as C Reactive protein (CRP), serum amyloid A (SAA) and other markers serve as biomarkers of systemic inflammation and are associated with poor prognosis in cancer patients.18,19 While these biomarkers have been thoroughly investigated across different cancer types, their routine availability for clinical testing is limited due to cost and accessibility constraints. Here, CRP is linked to cancer.